Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
Company overview

Synact Pharma: Interview with CEO Jeppe Øvlesen and CSO Thomas Jonassen (video call)

Redeye Research Interview timeStamp 2020/05/12

Synact Pharma comments on its early Phase IIa data in Rheumatoid Arthritis.

Ludvig Svensson

Ludvig Svensson

Equity Analyst

Tagged companies

You need to be a Redeye member to access this content

Become a member to:

By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions